Rejuveron Life Sciences Company

Rejuveron Life Sciences AG is a biotechnology company that focuses on developing therapies and technologies to improve healthy aging and prolong lifespan. They are a team of drug discovery and development experts who are driven by curiosity about aging.

Last Funding Type: Series B
Funding Status: Early Stage Venture
Headquarters: Schlieren, Zurich, Switzerland
Founded Date: 2019-01-01
Last Funding Date: 2022-03-17
Total Funding: 25102061
Employee Number: 1-10
Estimated Revenue: EUR 15.7 million
Investors Number: 11
Industry: Anti-aging Therapies